Παρασκευή 8 Σεπτεμβρίου 2017

Exploiting poly(I:C) to induce cancer cell apoptosis.

Exploiting poly(I:C) to induce cancer cell apoptosis.

Cancer Biol Ther. 2017 Sep 07;:0

Authors: Bianchi F, Pretto S, Tagliabue E, Balsari A, Sfondrini L

Abstract
TLR3 belong to the Toll-like receptors family, it is mainly expressed on immune cells where it senses pathogen-associated molecular patterns and initiates innate immune response. TLR3 agonist poly(I:C) was developed to mimic pathogens infection and boost immune system activation to promote anti-cancer therapy. Accordingly, TLR agonists were included in the National Cancer Institute list of immunotherapeutic agents with the highest potential to cure cancer. Besides well known effects on immune cells, poly(I:C) was also shown, in experimental models, to directly induce apoptosis in cancer cells expressing TLR3. This review presents the current knowledge on the mechanism of poly(I:C)-induced apoptosis in cancer cells. Experimental evidences on positive or negative regulators of TLR3-mediated apoptosis induced by poly(I:C) are reported and strategies are proposed to successfully promote this event in cancer cells. Cancer cells apoptosis is an additional arm offered by poly(I:C), besides activation of immune system, for the treatment of various type of cancer. A further dissection of TLR3 signaling would contribute to greater resolution of the critical steps that impede full exploitation of the poly(I:C)-induced apoptosis. Experimental evidences about negative regulator of poly(I:C)-induced apoptotic program should be considered in combinations with TLR3 agonists in clinical trials.

PMID: 28881163 [PubMed - as supplied by publisher]



http://ift.tt/2xhtQcn

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου